Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00303381
Status:
COMPLETED
Last Update Posted:
2013-08-06
First Post:
2006-03-14
Brief Title:
Safety and Efficacy of Interferon-Beta-1a Rebif for Treating Subjects With Acute Symptoms of Ulcerative Colitis
Sponsor:
EMD Serono
Organization:
EMD Serono
Study Overview
Official Title:
A Multicentre Randomised Double-blind Placebo-controlled Dose-finding Phase II Study of Subcutaneously Administered IFN-beta-1a in the Treatment of Patients With Moderately Active Ulcerative Colitis
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety and efficacy of interferon-beta-1a in subjects with active ulcerative colitis UC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None